Recent Research | Page 12 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort ascending Journal Bone Marrow Disease
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes Jan 2017 Cancer myelodysplastic syndromes (MDS)
MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia Jan 2017 Leuk Lymphoma myelodysplastic syndromes (MDS)
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia Jan 2017 Int J Hematol aplastic anemia
Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents Jan 2017 Am J Hematol myelodysplastic syndromes (MDS)
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results Jan 2017 Bone Marrow Transplant aplastic anemia
The value of survival gains in myelodysplastic syndromes. Jan 2017 Am J Manag Care myelodysplastic syndromes (MDS)
Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study Jan 2017 Thromb Res aplastic anemia
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes. Jan 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes. Jan 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate Jan 2017 Expert Rev Hematol myelodysplastic syndromes (MDS)